Shanghai Haixin Group Co., Ltd.

XSSC:600851 Stock Report

Market Cap: CN¥5.8b

Shanghai Haixin Group Past Earnings Performance

Past criteria checks 5/6

Shanghai Haixin Group has been growing earnings at an average annual rate of 8.2%, while the Pharmaceuticals industry saw earnings growing at 9.1% annually. Revenues have been growing at an average rate of 1.6% per year. Shanghai Haixin Group's return on equity is 4.7%, and it has net margins of 21.2%.

Key information

8.2%

Earnings growth rate

8.3%

EPS growth rate

Pharmaceuticals Industry Growth10.9%
Revenue growth rate1.6%
Return on equity4.7%
Net Margin21.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Shanghai Haixin Group makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

XSSC:600851 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2484117936325
30 Jun 2496416640824
31 Mar 241,10917243823
31 Dec 231,18316645623
30 Sep 231,33812047422
30 Jun 231,42914151323
31 Mar 231,42016354822
31 Dec 221,44016457822
30 Sep 221,46515363923
30 Jun 221,38114063022
31 Mar 221,56013664725
31 Dec 211,51113265324
30 Sep 211,29014864823
30 Jun 211,27214459924
31 Mar 211,00213054621
31 Dec 2093311946422
30 Sep 2098012943721
30 Jun 201,03712643820
31 Mar 201,0729446220
31 Dec 191,11210448120
30 Sep 191,16812741518
30 Jun 191,11312641516
31 Mar 191,11514037017
31 Dec 181,09913537616
30 Sep 181,06611342114
30 Jun 181,04412339021
31 Mar 181,02411336616
31 Dec 171,00010533413
30 Sep 171,0142632910
30 Jun 171,012313230
31 Mar 17997913150
31 Dec 161,012903040
30 Sep 161,0011892900
30 Jun 161,0581802890
31 Mar 161,0691532810
31 Dec 151,0521572820
30 Sep 151,0962962960
30 Jun 151,0943692930
31 Mar 151,0993272910
31 Dec 141,1102912930
30 Sep 141,1661313060
30 Jun 141,215353050
31 Mar 141,24303050
31 Dec 131,262653010

Quality Earnings: 600851 has high quality earnings.

Growing Profit Margin: 600851's current net profit margins (21.2%) are higher than last year (9%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 600851's earnings have grown by 8.2% per year over the past 5 years.

Accelerating Growth: 600851's earnings growth over the past year (49.3%) exceeds its 5-year average (8.2% per year).

Earnings vs Industry: 600851 earnings growth over the past year (49.3%) exceeded the Pharmaceuticals industry -2.5%.

Return on Equity

High ROE: 600851's Return on Equity (4.7%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 09:04
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai Haixin Group Co., Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Guoxian JuFirst Capital Securities Co. LTD.
Jun LingPing An Securities Co. Ltd.
Aarti PathakVirtua Research Inc.